Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
1999-03-26
2002-12-24
Lankford, Jr., Leon B. (Department: 1651)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S355000, C435S372000, C435S377000, C435S384000, C435S385000, C435S387000
Reexamination Certificate
active
06498034
ABSTRACT:
BACKGROUND OF THE INVENTION
Substantial numbers of functional dentritic cells (DC) can be generated from precursor cells in blood or bone marrow upon in vitro culture with appropriate combinations of cytokines. For the in vitro development of DC from human CD34
+
progenitor cells the most efficient cytokine combination was found to be GM-CSF plus TNF&agr; and SCF. The culture media used for growing functional DC from progenitor cells were not only supplemented with exogenous cytokines, however, but also with serum or plasma. This raised the question whether, in addition to the added cytokines, also as yet undefined serum components play a critical role in the in vitro DC development. TGF-&bgr;1, known to be present in serum and plasma samples, is such a component. In its presence, but not or only minimally in its absence can substantial numbers of DC be generated from CD34
+
progenitor cells also under serum/plasma-free conditions.
SUMMARY OF THE INVENTION
The invention concerns a process for the production of DC under serum/plasma-free conditions in the presence of TGF-&bgr;1.
REFERENCES:
patent: 6004807 (1999-12-01), Banchereau et al.
Mayani et al., Experimental Hematology, 23:422-427, 1995.
Jaffe, Pediatric Pathology, 13:821-837, 1993.
Lardon et al., Experimental Hematology, 22:903-908, 1994.
Snoeck et al., J. Exp. Med., 183:705-710, 1996.
Thomas et al., Stem Cells, 14:196-206, 1996.*
Williams et al., International Review of Cytology, 153:41-103, 1994.*
Strobl et al., TGF-B1 Promotes in Vitro Development Dendritic Cells from CD34+ Hemopoietic Progenitors1, 1996, The Journal of Immunology, vol. 157, pp. 1499-1507.
Inaba et al., J. Exp. Med, vol. 176, “Generation of Large Numbers of Dendritic Cells from Mouse Bone Marrow Cultures Supplemented with Granulocyte/Macrophage Colony-stimulating Factor,” pp. 1693-1702 (1992).
Kashihara et al., J. of Investigative Dermatology, vol. 87 (5), “A Monoclonal Antibody Specifically Reactive to Human Langerhans Cells,” pp. 602-607 (1986).
Knapp et al., Annals of Hematology, vol. 70, “Molecular characterization of CD34+ human hematopoietic progenitor cells,” pp. 281-296 (1995).
Bello-Fernandez C. et al., Human Gene Therapy, vol. 8, “Efficient Retrovirus-Mediated Gene Transfer of Dendritic Cells Generated from CD34+ Cord Blood Cells under Serum-Free Conditions,” pp. 1651-1658 (1997).
Bender A. et al., J. of Immunological Methods, vol. 196, “Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood,” pp. 121-135 (1996).
Borkowski T. et al., J. of Experimental Medicine, vol. 184, “A Role for Endogenous Transforming Growth Factor &bgr;1 in Langerhans Cell Biology: The Skin of Transforming Growth Factor &bgr;1 Null Mice is Devoid of Epidermal Langerhans Cells,” pp. 2417-2422 (1996).
Cashman J. et al., Blood, vol. 75, “Mechanisms That Regulates the Cell Cycle Status of Very Primitive Hematopoietic Cells in Long-Term Human Marrow Cultures. I. Stimulatory Role of a Variety of Mesenchymal Cell Activators and Inhibitory Role of TGF-&bgr;,” pp. 96-101 (1990).
Caux C. et al., J. Exp. Med., vol. 184, “CD3430Hematopoietic Progenitors from Human Cord Blood Differentiate Along Two Independent Dendritic Cell Pathways in Response to GM-CSF+TNF&agr;,” pp. 695-706 (1996).
Caux C. et al., Nature, vol. 360, “GM-CSF and TNF-&agr; cooperate in the generation of dendritic Langerhans cells,” pp. 258-261 (1992).
Cruz P. et al., J. of Investigative Dermatology, vol. 92 (2), “Disparate Effects of In Vitro Low-Dose UVB Irradiation on Intravenous Immunization with Purified Epidermal Cell Subpopulations for the Induction of Contact Hypersensitivity,” pp. 160-165 (1989).
Enk A. et al., J. of Immunology, vol. 151 (5), “Inhibition of Langerhans Cell Antigen-Presenting Function by IL-10 (A Role for IL-10 in Induction of Tolerance),” pp. 2390-2398 (1993).
Finkelman F. et al., J. of Immunology, “Dendritic Cells Can Present Antigen In Vivo in a Tolerogenic or Immunogenic Fashion,” pp. 1406-1414 (1996).
Flores-Romo L. et al., J. Exp. Med., vol. 185(2), “CD40 Ligation on Human Cord Blood CD3430Hematopoietic Progenitors Induces Their Proliferation and Differentiation into Functional Dendritic Cells,” pp. 341-349 (1997).
Hatzfeld J. et al., J. Exp. Med., vol. 174, “Release of Early Human Hematopoietic Progenitors from Quiescence by Antisense Transforming Growth Factor &bgr;1 or Rb Oligonucleotides,” pp. 925-929 (1991).
Imbert A.M. et al., Exp. Hematology, vol. 26, “A neutralizing anti-TGF-&bgr;1 antibody promotes proliferation of CD34+Thy-1+peripheral blood progenitors and increases the number of transduced progenitors,” pp. 374-381 (1998).
Lardon F. et al., Exp. Hematology, vol. 22, “Transforming growth factor-&bgr; regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus,” pp. 903-909 (1994).
Lu L. et al., Experimental Hematology, vol. 21, “Comparative effects of suppressive cytokines on isolated single CD34+++ stem/progenitor cells from human bone marrow and umbilical cord blood plated with and without serum,” pp. 1442-1446 (1993).
Reid C. et al., J. of Immunology, vol. 149 (8), “Interactions of Tumor Necrosis Factor with Granulocyte-Macrophage Colony-Stimulating Factor and Other Cytokines in the Regulation of Dendritic Cell Growth In Vitro from Early Bipotent CD34+Progenitors in Human Bone Marrow,” pp. 2681-2688 (1992).
Riedl E. et al., J. of Immunology, vol. 158, “TGF-&bgr;1 Promotes In Vitro Generation of Dendritic Cells by Protecting Progenitor Cells from Apoptosis,” pp. 1591-1597 (1997).
Roman N. et al., J. of Immunological Methods, vol. 196, “Genration of mature dendritic cells from human blood: An improved method with special regard to clinical applicability,” pp. 137-151 (1996).
Sauder D. et al., J. of Immunology, vol. 127 (1), “Induction of Tolerance to Topically Applied TNCB Using TNP-Conjugated Ultraviolet Light-Irradiated Epidermal Cells,” pp. 261-265 (1981).
Siena S. et al., Experimental Hematology, vol. 23, “Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy,” pp. 1463-1471 (1995).
Simon J. et al., J. of Immunology, vol. 146 (2), “Ultraviolet B Radiation Converts Langerhans Cells from Immunogenic Antigen-Presenting Cells,” pp. 485-491 (1991).
Steinman R., Annu. Rev. Immunol., vol. 9, “The Dendritic Cell System and its Role in Immunogenicity,” pp. 271-296 (1991).
Steinman R. et al., J. Invest Dermatol., vol. 105 (1) [Supplement], “Maturation and Migration of Cutaneous Dendritic Cels,” pp. 2S-7S (1995).
Steptoe R.J. and Thomson A. W., Clin. and Exp. Immunol., vol. 105, “Dendritic cells and tolerance induction,” pp. 397-402 (1996).
Strobl H. et al., Blood, vol. 90 (4), “flt3 Ligand in Cooperation with Transforming Growth Factor &bgr;-1 Potentiates In Vitro Development of Langerhans-Type Dendritic Cells and Allows Single-Cell Dendritic Cell Cluster Formation Under Serum-Free Conditions,” pp. 1-10 (1997).
Strobl H. et al., J. Immunol., vol. 157, “TGF-&bgr;1 Promotes In Vitro Development of Dendritic Cells from CD34° Hemopoietic Progenitors,” pp. 1499-1507 (1996).
Strobl H. et al., Immunobiology, vol. 198, “Epidermal Langerhans Cell Development and Differentation,” pp. 588-605 (1997/1998).
Szabolcs P. et al., J. Immunol., “Expansion of Immunostimulatory Dendritic Cells Among the Myeloid Progeny of Human CD34+ Bone Marrow Precursors Cultured with c-kitLigand, Granulocyte-Macrophage Colony-Stimulating Factor, and TNF-&agr;,” pp. 5851-5860 (1995).
Young J. et al., J. Exp. Med., vol. 182, “Identification of Dendritic Cell Colony-forming Units among Normal Human CD34+Bone Marrow Progenitors That Are Expandedby c-kit-ligand and Yield Pure Dendritic Cell Colonies in the Presence of Granulocyte/Macrophage Colony-stimulating Factor and Tumor Necrosis Factor &agr;,” pp. 1111-1120 (1995).
Yu J. et al., Gene Therapy, v
Lankford , Jr. Leon B.
Novartis AG
Pfeiffer Hesna J.
LandOfFree
Method of producing dendritic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of producing dendritic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing dendritic cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2940320